GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we handle type 2 diabetes . These new therapies work by stimulating the body’s natural GLP-1 https://listingbookmarks.com/story21768776/glp-1-a-significant-approach-in-blood-sugar-care